Evaluation of the "Blue Halo Coil Catheter" for Patients With Prostatic Obstruction (BlueHaloCoil)
Urinary Retention
About this trial
This is an interventional treatment trial for Urinary Retention
Eligibility Criteria
Inclusion Criteria: Male subjects > 50 years of age Able to provide consent Participants in urinary retention with post void residual > 350 cc Urinary retention is due to BPH with a prostate volume > 50cc or a prostatic urethral length of 5+ cm Subjects with a PSA > 4 ng/ml and a PSA density of 0.1 or less Subjects on alpha- blocking drugs or 5-alpha-reductase inhibitor drugs may be included Exclusion Criteria Inability to undergo bladder catheterization ( i.e. urethral stricture) Presence of gross hematuria Lack of cognitive ability to give consent or keep appointments History of Prostate Cancer Subject with a PSA > 4 ng/ml and a PSA density of > 0.1 will require prostate biopsy to rule out prostate cancer in order to be considered for study enrollment A subject with a prostate nodule will require biopsy to exclude cancer diagnosis Subject with a PSA > 10 ng/ml Subject taking LHRH analogs or anti-androgen drugs
Sites / Locations
- Florida Urology PartnersRecruiting
- Vero Urology CenterRecruiting
- Urology Clinics of North TexasRecruiting
Arms of the Study
Arm 1
Experimental
single arm study
The indication for use of the Blue Halo Coil Catheter is to facilitate bladder drainage in adult male patients with urinary retention due to benign prostatic hyperplasia. The device is inserted for temporary use up to 28 days.